Donald Trump Jr. and Eric Trump are participating in Dominari Holdings' private placement and are joining its advisory board.

Moleculin Biotech received FDA guidance reducing its Phase 3 trial size for Annamycin in AML. First unblinding is expected in ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

We recently compiled a list of the 10 Cheap Biotech Stocks to Invest in Now. In this article, we are going to take a look at ...

Moleculin Biotech, Inc. filed a Form 8-K with the Securities and Exchange Commission, announcing the company’s entry into a warrant exercise inducement offer letter. The letter, which was signed with ...

Biotech stocks are revolutionizing healthcare with breakthrough innovations, leading the charge in precision therapies and ...

Moleculin Biotech (NASDAQ:MBRX – Get Free Report) was downgraded by stock analysts at Maxim Group from a “buy” rating to a “hold” rating in a report issued on Wednesday, MarketBeat reports. Separately ...

Many investors seemed to view Nvidia's decision to maintain its stake in Recursion as a vote of confidence in the company.

Financial writer advises caution on Jyong Biotech Ltd. IPO due to high debt, legal issues, and FDA challenges. Click for my ...